Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-02-18 | New | $1,000,000 | $1,000,000 | Debt Only | 06b | SEC link |
| 2025-02-12 | New | $600,000 | $600,000 | Debt Only | 06b | SEC link |
| 2024-12-11 | New | $13,388,889 | $13,388,889 | Debt Only | 06b | SEC link |
| 2017-05-11 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
| 2013-04-09 | New | $5,050,050 | $5,050,050 | Equity Only | 06 | SEC link |
| 2011-12-29 | New | $2,829,243 | $2,829,243 | Equity Only | 06 | SEC link |
| 2009-11-18 | New | $249,750 | Unknown | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| Paul Marc Belsky | Director |
| Vadim Deyev | Executive |
| Jennifer Lynn Harris | Executive |
| Jeffrey Hutchins | Executive |
| Scott Katzman | Director |
| Michael Kharitonov | Director |
| John Monahan | Director |
| William Ostrander | Executive |
| John Prendergast | Director |
| Ann Rosar | Executive |
| Sandra Leta Silberman | Executive |
| Edward Smith | Director |
| Edward Byron Smith, Iii | Director |
| Taffy Williams | Executive |
| Jeffrey Wolf | Director, Executive |
| Jeff Wolf | Director, Executive |